Inventor · disambiguated record
Darren Mark Le Grand
Also filed as: LE GRAND DARREN · LE GRAND DARREN M · LE GRAND DARREN MARK
11 granted patents·8 pending applications·127 citations·filing 2000–2025
87Inventor score
Top patents by PatentIndex Score
19 records- 0194US6589950B1Purine derivatives inhibitors of tyrosine protein kinase SYKNOVARTIS AG·Filed 2000·Granted Jul 8, 2003·106 cites·12 claims
- 0283US8404684B2Inhibitors of phosphatidylinositol 3-kinaseBRUCE IAN·Filed 2011·Granted Mar 26, 2013·9 cites·10 claims
- 0376US11911371B2Pyridine and pyrazine derivative for the treatment of chronic bronchitisNOVARTIS AG·Filed 2021·Granted Feb 27, 2024·0 cites·22 claims
- 0469US10450298B2PET Imaging agentsAUBERSON YVES·Filed 2016·Granted Oct 22, 2019·1 cites·12 claims
- 0568US9630945B2Autotaxin inhibitorsFURMINGER VIKKI·Filed 2013·Granted Apr 25, 2017·4 cites·4 claims
- 0666US2019262324A1Pyridine and Pyrazine Derivative for the Treatment of CFNOVARTIS AG·Filed 2018·Application pending·0 cites
- 0764US7902375B25-phenyl-4-methyl-thiazol-2-yl-amine derivatives as inhibitors of phosphatidylin ositol 3 kinase enzymes (PI13) for treatment of inflammatory diseasesNOVARTIS AG·Filed 2004·Granted Mar 8, 2011·1 cites·2 claims
- 0863US7288537B2Azetidine derivatives as CCR-3 receptor antagonistsNOVARTIS AG·Filed 2003·Granted Oct 30, 2007·4 cites·19 claims
- 0962US10865195B2Pet imaging agentsNOVARTIS AG·Filed 2019·Granted Dec 15, 2020·0 cites·3 claims
- 1061US6670379B2Piperidine compounds for use as ccr-3 inhibitorsNOVARTIS AG·Filed 2001·Granted Dec 30, 2003·2 cites·20 claims
- 1157US2024300936A1Preparation of substituted 1,2-diaminoheterocyclic compound derivatives and their use as pharmaceutical agentsAVELOS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1257US2025352549A1Substituted heterocyclic compound derivatives and their pharmaceutical useAVELOS THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1351US2007032487A1Inhibitors of phosphatidylinositol 3-kinaseBRUCE IAN·Filed 2004·Application pending·0 cites
- 1450US2013172349A1Inhibitors of phosphatidylinositol 3-kinaseNOVARTIS AG·Filed 2013·Application pending·0 cites
- 1549US2011124693A15-phenyl-4-methyl-thiazol-2-yl-amine derivatives as inhibitors of phosphatidylinositol 3 kinase enzymes (pi3) for the treatment of inflammatory diseasesBLOOMFIELD GRAHAM CHARLES·Filed 2011·Application pending·0 cites
- 1649US2011124624A15-phenyl-4-methyl-thiazol-2-yl-amine derivatives as inhibitors of phosphatidylinositol 3 kinase enzymes (pi3) for the treatment of inflammatory diseasesBLOOMFIELD GRAHAM CHARLES·Filed 2011·Application pending·0 cites
- 1746US10183025B2Autotaxin inhibitorsNOVARTIS AG·Filed 2017·Granted Jan 22, 2019·0 cites·5 claims
- 1845US2007043013A11,3 Disubstituted azetidine derivatives for use as ccr-3 receptor antagonists in the treatment of inflammatory and allergic diseasesLE GRAND DARREN M·Filed 2004·Application pending·0 cites
- 1937US7034042B2N-(4-aryloxypiperidin-1-ylalkyl) cinnamic amides as CCR33 receptor antagonistsNOVARTIS AG·Filed 2001·Granted Apr 25, 2006·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Darren Mark Le Grand files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →